evekhm/cms_iom_500 huggingface dataset:
Article - Billing and Coding: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor (A57839)
CMS National Coverage PolicySocial Security Act (Title XVIII) Standard References:Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider of services or other person under this part unless there has been furnished such information as may be necessary in order to determine the amounts due such provider or other person under this part for the period with respect to which the amounts are being paid or for any prior period.Article TextThis Billing and Coding Article provides billing and coding guidance for Local Coverage Determination (LCD) L38495 Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor. Please refer to the LCD for reasonable and necessary requirements.Coding GuidanceNotice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. When billing for non-covered services, use the appropriate modifier.Documentation RequirementsAll documentation must be maintained in the patient's medical record and made available to the contractor upon request.Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient.The submitted medical record must support the use of the selected ICD-10-CM code(s). The submitted CPT/HCPCS code must describe the service performed.
Article - Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268) (A57842)
CMS National Coverage PolicyTitle XVIII of the Social Security Act, 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.CMS Internet-Only Manuals, Pub 100-02, Medicare Benefit Policy Manual, Chapter 15, 80.1.2 A/B MAC (B) Contacts With Independent Clinical LaboratoriesCMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 16, 50.5 Jurisdiction of Laboratory Claims, 60.1.1 Independent Laboratory Specimen Drawing, 60.2 Travel AllowanceArticle TextPlease note that CPTcodes 81265 and 81266 describe services performed for recipient/donor testingandtwin zygosity. Tests indicated for recipient/donor testing will be considered for payment and tests for twin zygosity will be denied as a statutorily excluded service. The following instructions outline the correct reporting of recipient/donor testing for transplant services.Chimerism analysis to identify appropriate donors and monitor engraftment success or disease reoccurrence is a covered Medicare service.Code 81265 should be reported with one unit of service (UOS). Except in rare cases, this service would only be performed once per lifetime.Code 81266, when used in bone marrow transplants to report an additional double-cord blood sample, is a covered service.Code 81267 should be used post transplantation to confirm successful engraftment or disease reoccurrence. Although the original donor specimen may be referenced, an additional 81265 should NOT be submitted in addition to the 81267 service. For labs that hold the pre-transplant specimen (81265 and/or 81266) until after the transplant occurs, use 81267 plus 81265 and 81266 if necessary.Note:Code 81267 should be reported for the findings of the pre and post-transplant comparison.Code 81268 should be used to report chimerism using a buccal or other germline tissue specimen from the recipient post-transplantation. For labs that hold the pre-transplant specimen (81265 and/or 81266) until after the transplant occurs, use 81267 plus 81265 and 81266 if necessary.
Article - Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268) (A57842)
MolDX would not expect to see a claim for 81265 pre-transplant and an additional 81265 and 81267 post-transplant or a claim for 81265 pre-transplant and an additional claim for 81268.EXCEPTIONS:Although the initial chimerism testing, code 81265, for engraftment is usually limited to once in a lifetime, MolDX recognizes special circumstances may require an additional service and will consider approval on a case-by-case basis through the appeal process.To report a Molecular Diagnostic Test service, please submit the following claim information:Select appropriate CPT codeEnter 1 unit of service (UOS)Enter the appropriate DEX Z-Codeidentifier adjacent to the CPTcode in the comment/narrative field for the following Part B claim field/types:Loop 2400 or SV101-7 for the 5010A1 837PItem 19 for paper claimEnter the appropriate DEX Z-Codeidentifier adjacent to the CPTcode in the comment/narrative field for the following Part A claim field/types:Line SV202-7 for 837I electronic claimBlock 80 for the UB04 claim formNOTE:When entering the DEX Z-Codeon the SV101-7 documentation field for Part B claims please do not add additional characters and/or information on the line.
Article - Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268) (A57843)
CMS National Coverage PolicyTitle XVIII of the Social Security Act, 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.CMS Internet-Only Manuals, Pub 100-02, Medicare Benefit Policy Manual, Chapter 15, 80.1.2 A/B MAC (B) Contacts With Independent Clinical LaboratoriesCMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 16, 50.5 Jurisdiction of Laboratory Claims, 60.1.1 Independent Laboratory Specimen Drawing, 60.2 Travel AllowanceArticle TextPlease note that CPTcodes 81265 and 81266 describe services performed for recipient/donor testingandtwin zygosity. Tests indicated for recipient/donor testing will be considered for payment and tests for twin zygosity will be denied as a statutorily excluded service. The following instructions outline the correct reporting of recipient/donor testing for transplant services.Chimerism analysis to identify appropriate donors and monitor engraftment success or disease reoccurrence is a covered Medicare service.Code 81265 should be reported with one unit of service (UOS). Except in rare cases, this service would only be performed once per lifetime.Code 81266, when used in bone marrow transplants to report an additional double-cord blood sample, is a covered service.Code 81267 should be used post transplantation to confirm successful engraftment or disease reoccurrence. Although the original donor specimen may be referenced, an additional 81265 should NOT be submitted in addition to the 81267 service. For labs that hold the pre-transplant specimen (81265 and/or 81266) until after the transplant occurs, use 81267 plus 81265 and 81266 if necessary.Note:Code 81267 should be reported for the findings of the pre and post-transplant comparison.Code 81268 should be used to report chimerism using a buccal or other germline tissue specimen from the recipient post-transplantation. For labs that hold the pre-transplant specimen (81265 and/or 81266) until after the transplant occurs, use 81267 plus 81265 and 81266 if necessary.
Article - Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268) (A57843)
MolDX would not expect to see a claim for 81265 pre-transplant and an additional 81265 and 81267 post-transplant or a claim for 81265 pre-transplant and an additional claim for 81268.EXCEPTIONS:Although the initial chimerism testing, code 81265, for engraftment is usually limited to once in a lifetime, MolDX recognizes special circumstances may require an additional service and will consider approval on a case-by-case basis through the appeal process.To report a Molecular Diagnostic Test service, please submit the following claim information:Select appropriate CPT codeEnter 1 unit of service (UOS)Enter the appropriate DEX Z-Codeidentifier adjacent to the CPTcode in the comment/narrative field for the following Part B claim field/types:Loop 2400 or SV101-7 for the 5010A1 837PItem 19 for paper claimEnter the appropriate DEX Z-Codeidentifier adjacent to the CPTcode in the comment/narrative field for the following Part A claim field/types:Line SV202-7 for 837I electronic claimBlock 80 for the UB04 claim formNOTE:When entering the DEX Z-Codeon the SV101-7 documentation field for Part B claims please do not add additional characters and/or information on the line.
Article - Billing and Coding: Tomosynthesis-Guided Breast Biopsy (A57848)
CMS National Coverage PolicyN/AArticle TextThis article is effective immediately.Tomosynthesis-guided percutaneous core needle biopsy utilizes the technique of digital breast tomosynthesis or 3-D mammography for identification of appropriate target sampling and intra-procedural needle placement. However, although digital breast tomosynthesis has become a more common screening and diagnostic modality; use of this technology for percutaneous breast biopsy is still on the rise. As a result, there may be uncertainty as to the proper coding and billing, since this procedure does not have a specifically assigned CPT code.It is Noridians experience that the billing and coding of this procedure is at high risk for error. Therefore, Noridian is providing billing and coding guidance for providers who perform tomosynthesis-guided percutaneous biopsy for the evaluation of abnormal breast tissue concerning for malignancy.If tomosynthesis is the only imaging guidance used for a breast biopsy, CPT code 19499 (Unlisted procedure, breast) should be utilized and the name of the procedure documented in the comments/narrative field for the followingPart Bclaim field/types:Loop 2400 or SV101-7 for the 5010A1 837PItem 19 for paper claimCPT code 19499 (Unlisted procedure, breast) should be utilized and the name of the procedure documented in the comments/narrative field for the followingPart Aclaim field/types:Line SV202-7 for 837I electronic claimBlock 80 for the UB04 claim form
Article - Billing and Coding: Tomosynthesis-Guided Breast Biopsy (A57848)
Block 80 for the UB04 claim formShould more than one lesion of either breast be biopsied using tomosynthesis-only guidance on the same date of service, modifier 59 should be coded if the additional lesion is on the same breast (e.g. 19499 and 19499-59 should be coded to indicate 2 separate lesions undergoing tomosynthesis-guided breast biopsy)or modifier -50 indicating bilateral procedure,if repeated on the opposite breast. The additional lesion(s) requiring biopsy (including which breast) must be clearly documented in the procedure note. Multiple surgery payment rules applied.If a percutaneous breast biopsy is performed using both stereotactic and tomosynthesis imaging guidance, CPT code 19081 (Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance) should be utilized.Should it be clinically necessary to use additional non-mammography imaging guidance to biopsy a breast lesion(s) either of the same or opposite breast, on the same date of service, this procedure will be denied unless modifier -59 (e.g. 19499-59) is also coded along with the additional imaging modality respective CPT code. Documentation provided must clearly support the need to switch modalities. Examples include: ultrasound-guided percutaneous breast biopsy CPT 19083-19084, MRI-guided percutaneous breast biopsy CPT 19085-19086, percutaneous biopsy without imaging guidance CPT 19100, and open incisional biopsy CPT 19101.In addition, CPT codes 19281-19288, related to the placement of a breast localization device (e.g. clip, metallic pellet, wire/needle, radioactive seeds) are not separately payable with 19499 as these procedure codes are considered part of the tomosynthesis-guided percutaneous breast biopsy procedure.Similarly, if a tomosynthesis-only guided placement of a breast localization device procedure is performed (without biopsy), CPT 19499 will also need to be utilized with clear description in the comments/narrative field for bothPart A and Part Bclaims.
Article - Billing and Coding: Tomosynthesis-Guided Breast Biopsy (A57848)
Another issue is the common practice of obtaining a post-biopsy mammogram to confirm marker placement, assess for complications, etc. It is Noridians interpretation that a follow-up mammogram performed post tomosynthesis-guided breast biopsy will be considered part of the procedure and not separately payable, regardless of whether the patient is brought to a different room and/or unit for the mammography.Post- biopsy mammograms (77065 and/or 77067, with or without G0279) coded and billed for the same date of service, regardless of the timing, separation, number, and/or order of claims billed, will not be considered separately payable.Should either 19499 and/or 77065/77067 be coded and billed on separate claims, resulting in one of the codes being paid prior, additional payment by Noridian for the other billed service will be subject to payment adjustment and/or denial, taking previous payment into consideration.ReferencesCurrent Procedural Terminology (CPT) ManualCPT Assistant 2019 - Frequently Asked Questions, December 2016, Volume 26, Issue 12, page 16
Physician Fee Schedule | CMS
htmlPhysician Fee Schedule | CMSSkip to main contentAn official website of the United States governmentHere's how you knowHere's how you knowOfficial websites use .govA.govwebsite belongs to an official government organization in the United States.Secure .gov websites use HTTPSAlock()orhttps://means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.Centers for Medicare & Medicaid ServicesCMS NewsroomHeaderAbout CMSNewsroomData & ResearchSearch CMS.govSearchSearchPopular termsPhysician Fee ScheduleLocal Coverage DeterminationMedically Unlikely EditsTelehealthCovid-19CMS.gov main menuMedicareBack to main menusection title h2Enrollment & renewalBack tomenusection title h3Annual Medicare Participation AnnouncementProviders & suppliersMedicare Managed Care Eligibility and EnrollmentPart D plansHealth plansHealth Care Prepayment Plans (HCPPs)Cost plansSpecial needs plansCoverageBack tomenusection title h3Coverage Determination ProcessMedicare Coverage DatabaseApproved facilities, trials, & registriesTelehealthMedicare Summary NoticePrescription drug coverage contractingCoverage with evidence developmentInvestigational device exemption studiesPrescription drug coverageDrug coverage claims dataDental coveragePreventive ServicesMedicare Coverage CenterEnd Stage Renal Disease (ESRD) CenterAmbulances Services CenterRegulations & guidanceBack tomenusection title h3ManualsTransmittalsCMS Records ScheduleMedicare Fee-for-Service payment regulationsNational Provider Identifier Standard (NPI)Advisory committeesLegislationPromoting Interoperability ProgramsCMS rulemakingCMS Hearing OfficerOffice of the Attorney Advisor (OAA)Provider Reimbursement Review Board (PRRB)Medicare Geographic Classification Review Board (MGCRB)Physician Self-ReferralQuarterly provider updatesE-PrescribingCoding & billingBack tomenusection title h3Place of service codesICD-10 codesHealthcare Common Procedure Coding System (HCPCS)Outpatient Code Editor (OCE)National Correct Coding Initiative (NCCI) editsNCCI for MedicaidElectronic billingMedicare Administrative Contractors (MACs)Provider Customer Service ProgramSkilled Nursing Facility (SNF) consolidated billingRoster billingTherapy servicesMedicare claims & public health emergenciesGuide for Medical Technology Companies and Other Interested PartiesPaymentBack tomenusection title h3Medicare Part B Drug Average Sales PriceAll Fee-For-Service-ProvidersFee schedulesProspective Payment SystemsOpioid Treatment Programs (OTP)
Physician Fee Schedule | CMS
Guide for Medical Technology Companies and Other Interested PartiesPaymentBack tomenusection title h3Medicare Part B Drug Average Sales PriceAll Fee-For-Service-ProvidersFee schedulesProspective Payment SystemsOpioid Treatment Programs (OTP)Covid-19 Vaccine ToolkitBankruptcySustainable Growth Rates & Conversion FactorsMedicare Advantage Rates & StatisticsHealth plan paymentMedicare-Medicaid coordinationBack tomenusection title h3Medicare-Medicaid Coordination OfficeQualified Medicare beneficiary programFinancial alignment initiativeInitiative to reduce avoidable hospitalizationsProgram of All-Inclusive Care for the Elderly (PACE)Resources for Medicare-Medicaid plansResources for state Medicaid agenciesCenter for Program IntegrityHealthcare Fraud Prevention PartnershipClinical TemplatesAppeals & grievancesBack tomenusection title h3Original Medicare appealsManaged Care appeals & grievancesPrescription drug appeals & grievancesOmbudsman CenterAppeals Decision Search (Part C & Part D)QualityBack tomenusection title h3Value-based programsPerson & Family EngagementQuality improvement organizationsNursing home quality improvementInpatient Rehabilitation Facility (IRF) Quality Reporting Program (QRP)Home Health Quality Reporting ProgramESRD Quality Incentive ProgramCMS National Quality StrategyHospice Quality Reporting ProgramLong-Term Care Hospital (LTCH) Quality Reporting Program (QRP)Appropriate Use Criteria ProgramQuality measuresClinical Laboratory Improvement Amendments (CLIA)Medicare Advantage quality improvement programPhysician compare initiativeQuality initiativesPart C and D Performance DataSkilled Nursing Facility (SNF) Quality Reporting Program (QRP)Health & safety standardsBack tomenusection title h3Quality, safety & oversight - General informationAccreditation programsCivil monetary penaltiesMedicare termination noticesQuality, safety & oversight - Emergency preparednessState survey agenciesCertification & complianceEnforcementQuality, safety & oversight - Guidance for laws & regulationsPromising practices projectQuality, safety & oversight - Education division (QSED)Conditions for coverage & participationEmployers & plan sponsorsBack tomenusection title h3Creditable coverageIC-Placeholder-1Audits & ComplianceBack tomenusection title h3Part A cost report auditPart C/Part D compliance & auditsForms & noticesBack tomenusection title h3CMS formsCMS forms listBeneficiary Notices Initiative (BNI)Health & drug plansBack tomenusection title h3Plan paymentPlan payment dataMedical loss ratioCoverage Gap Discount ProgramManaged care marketingMedicare Advantage applicationMedigap (Medicare supplement health insurance)Medical Savings Account (MSA)
Physician Fee Schedule | CMS
Health & drug plansBack tomenusection title h3Plan paymentPlan payment dataMedical loss ratioCoverage Gap Discount ProgramManaged care marketingMedicare Advantage applicationMedigap (Medicare supplement health insurance)Medical Savings Account (MSA)Private Fee-for-Service PlansNetwork adequacyCoordination of benefits & recoveryBack tomenusection title h3OverviewMandatory Insurer Reporting for Group Health Plans (GHP)Mandatory insurer reporting (NGHP)Workers' comp Medicare set aside arrangementsAttorney servicesBeneficiary servicesCOBA Trading PartnersEmployer servicesInsurer servicesPrescription drug assistance programsProvider servicesSettlementsBack tomenusection title h3Jimmo SettlementRyan SettlementMedicaid/CHIPBack to main menusection title h2What is Medicaid?Back tomenusection title h3Visit Medicaid.govView Medicaid mapsVisit CHIP.govMedicare-Medicaid CoordinationBack tomenusection title h3Integrated care resourcesInitiative to reduce avoidable hospitalizationsFinancial alignment initiativeMedicaid Integrity InstituteRG-Placeholder-1IC-Placeholder-2Marketplace & Private InsuranceBack to main menusection title h2About the MarketplaceBack tomenusection title h3Marketplace oversightAffordable Care ActOverview of the exchangesExchange coverage mapsMedicare and the MarketplacePrivate Health InsuranceBack tomenusection title h3Patients Bill of RightsMedical loss ratioAnnual limitsReview of insurance ratesMarket ratingSelf-funded, non-federal governmental plansGrandfathered plansHealth Reimbursement ArrangementsCoverage for young adultsStudent health plansMental health parity and addiction equityPreventionConsumer protections & enforcementPre-existing condition insurance planQualifying Health Coverage (QHC)RG-Placeholder-2In-person assistersBack tomenusection title h3Information for PartnersAssister outreach & educationApplications, forms, & noticesAssister programs & proceduresAssister technical resourcesAssister training & webinarsAgents & BrokersBack tomenusection title h3Resources for Agent & BrokersRegistration & trainingOpen enrollmentDirect enrollment partnersGeneral resourcesVideo Learning CenterAgent & Broker FAQMarketplace help desk & call centersRegistration Completion ListMarketplace Registration TrackerAB Suspension & Termination ListFind local helpIssuer and direct enrollment partner directoryHelp on demandSHOP ResourcesHealth Plans & IssuersBack tomenusection title h3Qualified health plan certificationSummary of benefits & coverageInsurance programsPremium stabilization programsHealth insurance market reformsMinimum essential coverageEmployers & sponsorsBack tomenusection title h3CoverageRegulation & guidance
Physician Fee Schedule | CMS
SHOP ResourcesHealth Plans & IssuersBack tomenusection title h3Qualified health plan certificationSummary of benefits & coverageInsurance programsPremium stabilization programsHealth insurance market reformsMinimum essential coverageEmployers & sponsorsBack tomenusection title h3CoverageRegulation & guidanceSmall business tax credit & premium assistanceAppealsSmall Business Health Options Program (SHOP)Early retiree reinsurance programEmployer initiativesStatesBack tomenusection title h3Planning & establishing a MarketplaceTerritory cooperative agreementsEarly innovator programState flexibility to stabilize the MarketSection 1332 (State Innovation) WaiverExchange establishment grantsPre-existing condition insurance planResourcesBack tomenusection title h3About UsData resourcesFact sheets & FAQsForms, reports, & other resourcesFunding opportunitiesLettersRegulations & GuidanceTraining resourcesPrioritiesBack to main menusection title h2Innovation CenterBack tomenusection title h3OverviewAboutKey ConceptsValue-Based Care SpotlightInnovation ModelsWhere Innovation is HappeningEventsData & ReportsHealth EquityBack tomenusection title h3Coverage to CareMinority healthCobertura de atencinGrants & awardsRecent LegislationBack tomenusection title h3Inflation Reduction Act and MedicareNo Surprises ActKey InitiativesBack tomenusection title h3OpioidsFluMedicare Open EnrollmentMedicare OE partner resourcesMarketplace Open EnrollmentE-healthOpen PaymentsBurden reductionReturning to regular operations after COVID-19Healthplan price transparencyHospital price transparencyLookup toolsGive feedbackYour Patient RightsBack tomenusection title h3Emergency room rightsMedical bill rightsTraining & EducationBack to main menusection title h2CMS National Training ProgramBack tomenusection title h3National Training Program resourcesClass modulesPartner outreach resourcesBack tomenusection title h3Partner with CMSNational Medicare Education Program (NMEP)Low-Income Subsidy (LIS) outreachBecome a champion for coverageFlu Vaccine Partner ToolkitFaith-Based PartnersRural Health PartnersAmerican Indian/Alaska NativePartnering with CMS CenterMedicare Learning Network (MLN)Back tomenusection title h3Resources & trainingNewsletterCompliancePartnershipsCMS Open Door ForumsBack tomenusection title h3About Open Door ForumsAmbulanceEnd-Stage Renal Disease (ESRD) & Clinical LaboratoriesHome Health, Hospice & Durable Medical Equipment (DME)HospitalLong-Term Services & SupportsPhysicians, Nurses and Allied Health ProfessionalsRural HealthSkilled Nursing Facilities (SNFs)/Long-Term CareSpecial Open Door forumsLook up topicsBack tomenusection title h3MedicareMedicaidCHIPAmerican Indian/Alaska Native Center